Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 2Supranuclear Palsy, Progressive 1Spinal Cord Injuries 1Prostatic Neoplasms 1Parkinson Disease 1Myasthenia Gravis 1Multiple System Atrophy 1Lewy Body Disease 1Hematologic Neoplasms 1Head and Neck Carcinoma 1Fatigue 1Essential Tremor 1Carcinoma, Renal Cell 1Alzheimer Disease 1

Interventions

Temozolomide 163Radiosurgery 128Radiotherapy 106Bevacizumab 97Magnetic Resonance Spectroscopy 74Carboplatin 48Surgical Procedures, Operative 35Etoposide 34pembrolizumab 33Radiation 33Nivolumab 33Irinotecan 33Cyclophosphamide 33Erlotinib Hydrochloride 31Carmustine 28Trastuzumab 25Lomustine 25Cisplatin 25Ipilimumab 24Filgrastim 23Mental Status and Dementia Tests 21Magnetic Resonance Imaging 21Aminolevulinic Acid 21Vincristine 20Surveys and Questionnaires 19Capecitabine 19Topotecan 18Specimen Handling 18Pemetrexed 18Radiotherapy, Intensity-Modulated 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Brain Neoplasms × Neurofeedback × Clear all
NCT07085494 2026-01-27

Neurofeedback and Cognitive Training for PBTS

The University of Hong Kong

Phase NA Enrolling by invitation
50 enrolled
CNS

Brain Neoplasms

NCT00961922 2012-10-04

PRISMA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Unknown
105 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡